Three months ago a patient diagnosed with binge eating disorder weighed 198 pounds.Lorcaserin (Belviq)was prescribed.Which current assessment finding indicates the need for reevaluation of this treatment approach? The patient:

Question

Quizplus · Accepted Answer

Lorcaserin is designed to make people feel full after eating smaller meals by activating a serotonin 2c receptor in the brain and blocking appetite signals.According to the FDA,this drug should be stopped if a patient does not have 5% weight loss after 12 weeks of use.If the patient now weighs 196 pounds,the medication has not been effective.The distracters indicate patient learning was effective and expected side effects of this medication.

Three Months Ago a Patient Diagnosed with Binge Eating Disorder